RetinalGenix Technologies (RTGN) EPS (Weighted Average and Diluted) (2022 - 2026)
RetinalGenix Technologies recorded quarterly EPS (Weighted Average and Diluted) of -$0.03 in Q1 2026, little changed quarter-over-quarter from -$0.03 in Q4 2025, and little changed year-over-year from -$0.03 in Q1 2025.
RetinalGenix Technologies' EPS (Weighted Average and Diluted) history runs 5 years deep, the most recent figure standing at -$0.03 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) changed 0.0% year-over-year to -$0.03; the TTM figure through Mar 2026 stood at -$0.12 (up 22.5% YoY), while the FY2025 annual figure was -$0.13, up 45.83% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.03 for Q1 2026 at RetinalGenix Technologies, roughly flat from -$0.03 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.02 in Q2 2022 to a low of -$0.15 in Q3 2022.
- A 5-year average of -$0.05 and a median of -$0.03 in 2023 frame the typical range for EPS (Weighted Average and Diluted).
- Across the five-year window, EPS (Weighted Average and Diluted) tumbled 300.0% in 2024 and surged 75.0% in 2025, its largest moves.
- RetinalGenix Technologies' EPS (Weighted Average and Diluted) stood at -$0.04 in 2022, then advanced by 25.0% to -$0.03 in 2023, then tumbled by 66.67% to -$0.05 in 2024, then soared by 40.0% to -$0.03 in 2025, then changed by 0.0% to -$0.03 in 2026.
- According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods registered -$0.03, -$0.03, and -$0.03 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | RetinalGenix Technologies | - | - | - | -0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.03 |
| Dec 31, 2025 | -0.03 |
| Sep 30, 2025 | -0.03 |
| Jun 30, 2025 | -0.03 |
| Mar 31, 2025 | -0.03 |
| Dec 31, 2024 | -0.05 |
| Sep 30, 2024 | -0.04 |
| Jun 30, 2024 | -0.04 |
| Mar 31, 2024 | -0.12 |
| Dec 31, 2023 | -0.03 |
| Sep 30, 2023 | -0.04 |
| Jun 30, 2023 | -0.02 |
| Mar 31, 2023 | -0.03 |
| Dec 31, 2022 | -0.04 |
| Sep 30, 2022 | -0.15 |
| Jun 30, 2022 | -0.02 |